High-Dimensional Single-Cell Analysis of Natural Killer Cell Heterogeneity in Human Blood
Cell therapy could benefit from BCG: how anti-tumour BCG-primed NK cells selectively proliferate over other lymphocytes and efficiently kill cancer cells
PD-1 regulates ILC3-driven intestinal immunity and homeostasis
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
Microbiota-dependent expression of CTLA-4 by innate lymphoid cells restrains IFNγ dependent colitis
Inhibition of multipotent ILC2s by JAK3 inhibitor attenuates steroid-resistant asthma
Human ILC1s target leukemia stem cells and control development of AML
Heat shock protein gp96 drives natural killer cell maturation and anti-tumor immunity by counteracting Trim28 to stabilize Eomes
Single-cell profiling identifies a CD8bright CD244bright Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy.
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria